Gannex Announces Positive Clinical Results in Overweight and Obese Subjects for Its THR-β Agonist ASC41 ...Middle East

SHANGHAI, Feb. 21, 2021 /PRNewswire/ -- Gannex, a wholly owned company of Ascletis Pharma Inc. (HKEX: 1672), fully dedicated to the R&D and commercialization of new drugs in the field of nonalcoholic steatohepatitis (NASH), announces the positive clinical results in overweight and obese...

Hence then, the article about gannex announces positive clinical results in overweight and obese subjects for its thr b agonist asc41 was published today ( Sunday 21/02/2021 - 03:16 PM ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Gannex Announces Positive Clinical Results in Overweight and Obese Subjects for Its THR-β Agonist ASC41 )

Also on site :

• Teenagers wreak havoc in Clapham during Easter holiday ‘link up’
• Spain’s FA condemns Islamophobic chants during game with Egypt
• Politics latest: Starmer to deliver cost of living update after latest Trump tirade over Iran war